Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 3, keine Gesamtzahl für „Adenuric“
Suchtreffer
Begriffe & Kennungen
Adenuric · 4.8 Undesirable effects · 2
Eintrag öffnenAdenuric · 4.8 · 22 which were associated to systemic symptoms, and rare events of sudden cardiac death, have occurred in the p
Eintrag öffnenAdenuric · 4.8 · 23 Dyspnoea Uncommon Bronchitis, upper respiratory tract infection, lower respiratory tract infection#, cough,
Eintrag öffnenAdenuric · 4.8 · 24 Thirst, feeling hot# Investigations Uncommon Blood amylase increase, platelet count decrease, WBC decrease,
Eintrag öffnenAdenuric · 4.8 · 6 Metabolism and nutrition Common*** disorders Gout flares Uncommon Diabetes mellitus, hyperlipidemia, decreas
Eintrag öffnenAdenuric · 4.8 · 7 Dermatitis, urticaria, skin discolouration, skin lesion, petechiae, rash macular, rash maculopapular, rash p
Eintrag öffnenAdenuric · 4.8 · 8 rashes associated with blisters or mucosal lesions and eye irritation. Hypersensitivity reactions to febuxos
Eintrag öffnenAdenuric · 4.8 · Cardiac disorders: Uncommon: Left bundle branch block, sinus tachycardia
Eintrag öffnenAdenuric · 4.8 · Description of selected adverse reactions Rare serious hypersensitivity reactions to febuxostat, including Ste
Eintrag öffnenAdenuric · 4.8 · Description of selected adverse reactions Rare serious hypersensitivity reactions to febuxostat, including Ste
Eintrag öffnenAdenuric · 4.8 · Gout flares were commonly observed soon after the start of treatment and during the first months. Thereafter,
Eintrag öffnenAdenuric · 4.8 · Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medi
Eintrag öffnenAdenuric · 4.8 · Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medi
Eintrag öffnenAdenuric · 4.8 · Summary of the safety profile The most commonly reported adverse reactions in clinical trials (4,072 subjects
Eintrag öffnenAdenuric · 4.8 · Summary of the safety profile The most commonly reported adverse reactions in clinical trials (4,072 subjects
Eintrag öffnenAdenuric · 4.8 · Table 1: Adverse reactions in combined phase 3, long-term extension studies, post-authorisation safety studies
Eintrag öffnenAdenuric · 4.8 · Table 1: Adverse reactions in combined phase 3, long-term extension studies, post-authorisation safety studies
Eintrag öffnenAdenuric · 4.8 · Tabulated list of adverse reactions Common (≥1/100 to <1/10), uncommon (≥1/1,000 to <1/100) and rare (≥1/10,00
Eintrag öffnenAdenuric · 4.8 · Tabulated list of adverse reactions Common (≥1/100 to <1/10), uncommon (≥1/1,000 to <1/100) and rare (≥1/10,00
Eintrag öffnenAdenuric · 4.8 · Tumor Lysis Syndrome Summary of the safety profile In the randomized, double-blind, Phase 3 pivotal FLORENCE (
Eintrag öffnen